Advertisement
Screener

WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Increase (Decrease) in Accrued Taxes Payable

WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Increase (Decrease) in Accrued Taxes Payable

WEIKANG BIO-TECHNOLOGY GROUP CO., INC. reported Increase (Decrease) in Accrued Taxes Payable of -$4.58 million for the 9-month period ending 2012-09-30, per its 10-Q/A filed 2012-12-11.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedTaxesPayable · last filed 2012-12-11

  • WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accrued taxes payable for the quarter ending 2012-09-30 was $43.46K, a 87.99% decline year-over-year.
  • WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accrued taxes payable for the quarter ending 2012-06-30 was -$3.87M.
  • WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accrued taxes payable for the quarter ending 2012-03-31 was -$761.91K.
  • WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accrued taxes payable for the quarter ending 2011-12-31 was $3.07M, a 3.00% increase year-over-year.
  • WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accrued taxes payable for fiscal 2011 was -$152.77K, a 103.95% decline from fiscal 2010.
  • WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accrued taxes payable for fiscal 2010 was $3.87M.
Period endIncrease (Decrease) in Accrued Taxes Payable 3 monthIncrease (Decrease) in Accrued Taxes Payable 6 monthIncrease (Decrease) in Accrued Taxes Payable 9 monthIncrease (Decrease) in Accrued Taxes Payable 12 month
2012-09-30$43.46K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-12-11
-$3.82M
derived: sum of 2 quarters · filed 2012-12-11
-$4.58M
10-Q/A · filed 2012-12-11
-$1.51M
derived: sum of 4 quarters · filed 2012-12-11
2012-06-30-$3.87M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30
-$4.63M
10-Q/A · filed 2012-08-30
-$1.55M
derived: sum of 3 quarters · filed 2012-08-30
-$1.19M
derived: sum of 4 quarters · filed 2012-12-11
2012-03-31-$761.91K
10-Q · filed 2012-05-15
$2.31M
derived: sum of 2 quarters · filed 2012-05-15
$2.67M
derived: sum of 3 quarters · filed 2012-12-11
$522.77K
derived: sum of 4 quarters · filed 2012-12-11
2011-12-31$3.07M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30
$3.44M
derived: sum of 2 quarters · filed 2012-12-11
$1.28M
derived: sum of 3 quarters · filed 2012-12-11
-$152.77K
10-K · filed 2012-03-30
2011-09-30$361.91K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-12-11
-$1.79M
derived: sum of 2 quarters · filed 2012-12-11
-$3.23M
10-Q/A · filed 2012-12-11
-$242.25K
derived: sum of 4 quarters · filed 2012-12-11
2011-06-30-$2.15M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30
-$3.59M
10-Q/A · filed 2012-08-30
-$604.16K
derived: sum of 3 quarters · filed 2012-08-30
$1.02M
derived: sum of 4 quarters · filed 2012-08-30
2011-03-31-$1.44M
10-Q · filed 2012-05-15
$1.55M
derived: sum of 2 quarters · filed 2012-05-15
$3.17M
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31$2.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
$4.61M
derived: sum of 2 quarters · filed 2012-03-30
$3.87M
10-K · filed 2012-03-30
2010-09-30$1.63M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21
$882.46K
10-Q · filed 2011-11-21
2010-06-30-$743.60K
10-Q/A · filed 2011-09-01